Home › Non-Hodgkin Lymphoma › Ohio › Akron
Non-Hodgkin Lymphoma clinical trials in Akron, OH
4 studies for Non-Hodgkin Lymphoma are looking for participants at sites in and around Akron (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
RecruitingPhase 3
- GC2202 Study Site 105, Canton · 21 mi away
A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL
RecruitingPhase 1/2
- GSK Investigational Site, Canton · 21 mi away
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Childrens Hospital Medical Center of Akron, Akron
Study of SGR-1505 in Mature B-Cell Neoplasms
RecruitingPhase 1
- Gabrail Cancer & Research Center, Canton · 21 mi away
Non-Hodgkin Lymphoma trials in other cities
- New York City, NY31 studies
- Houston, TX31 studies
- Boston, MA27 studies
- Nashville, TN22 studies
- Philadelphia, PA20 studies
- Baldwin Park, CA19 studies
- Milwaukee, WI19 studies
- Chicago, IL18 studies
- Columbus, OH18 studies
- Washington, DC18 studies
- Atlanta, GA18 studies
- Dallas, TX17 studies
Other studies in Akron
- Non-Small Cell Lung Cancer24 studies
- Lung Cancer17 studies
- Breast Cancer14 studies
- Cancer (all types)13 studies
- Prostate Cancer10 studies
- Metastatic Cancer8 studies
- Colorectal Cancer8 studies
- Small Cell Lung Cancer8 studies
- Acute Myeloid Leukemia8 studies
- Melanoma8 studies
- Steatotic Liver Disease7 studies
- Head and Neck Squamous Cell Carcinoma6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.